Advertisement
Canada markets open in 3 hours 54 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7312
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    82.82
    +0.01 (+0.01%)
     
  • Bitcoin CAD

    87,502.72
    -3,377.18 (-3.72%)
     
  • CMC Crypto 200

    1,363.23
    -19.35 (-1.40%)
     
  • GOLD FUTURES

    2,337.70
    -0.70 (-0.03%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,507.00
    -157.50 (-0.89%)
     
  • VOLATILITY

    16.19
    +0.22 (+1.38%)
     
  • FTSE

    8,084.17
    +43.79 (+0.54%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Is Sanofi Stock a Buy Now?

Is Sanofi Stock a Buy Now?

French pharmaceutical giant Sanofi (NASDAQ: SNY) has long been a leader in the market for insulin. First, Sanofi was forced to decrease the price of its most prescribed insulin product after its only two real competitors in this area did something similar. Second, Sanofi announced the acquisition of Provention Bio, a biotech focusing on developing medicines to delay or prevent the onset of autoimmune diseases, such as Type 1a diabetes.